TNF-α in 2024: Rewriting the Rules of Inflammation and Immune ModulationÂ
“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most promising—battleground.” Tumor